Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 7, 2014, Pages

  Bizzarro, Matthew ^a   Gross, Ian ^a   Barbosa, Fabiano T ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Hospital Geral do Estado Prof Osvaldo Brandão Vilela   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

METHEMOGLOBIN; NITRIC OXIDE; PLACEBO;

ARTERIAL OXYGEN SATURATION; ARTERIAL OXYGEN TENSION; CHILDHOOD MORTALITY; CONGENITAL HEART DISEASE; DISEASE SEVERITY; DRUG EFFICACY; HEART RATE; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; LONG TERM CARE; LUNG ARTERY PRESSURE; MEAN ARTERIAL PRESSURE; MENTAL DISEASE; META ANALYSIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; THERAPY EFFECT; TOXICITY; TREATMENT OUTCOME; CHILD; HEART DEFECTS, CONGENITAL; HEART DISEASES; HYPERTENSION, PULMONARY; INFANT; INHALATIONAL DRUG ADMINISTRATION; MORTALITY; POSTOPERATIVE COMPLICATIONS; PRESCHOOL CHILD;

ADMINISTRATION, INHALATION; CHILD; CHILD, PRESCHOOL; HEART DEFECTS, CONGENITAL; HEART DISEASES; HUMANS; HYPERTENSION, PULMONARY; INFANT; NITRIC OXIDE; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84922391947     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD005055.pub3     Document Type: Review

References (39)

1. Day RW, Hawkins JA, McGough EC, Crezee KL, Orsmond GS. Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Annals of Thoracic Surgery 2000;69(6):1907-13. [MEDLINE: PMID: 10892945]
2. Miller OI, Tang SF, Keech A, Pigott NB, Beller E, Celermajer DS. Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. Lancet 2000;356(9240):1464-9. [MEDLINE: PMID: 11081528]
3. Morris K, Beghetti M, Petros A, Adatia I, Bohn D. Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Critical Care Medicine 2000;28(8):2974-8. [MEDLINE: PMID: 10966281]
4. Russell IA, Zwass MS, Fineman JR, Balea M, Rouine-Rapp K, Brook M, et al. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesthesia and Analgesia 1998;87(1):46-51.
5. Argenziano M, Choudhri AF, Moazami N, Rose EA, Smith CR, Levin HR, et al. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Annals of Thoracic Surgery 1998;65(2):340-5. [MEDLINE: PMID: 9485226]
6. Checchia PA, Bronicki RA, Muenzer JT, Dixon D, Raithel S, Gandhi SK, et al. Nitric oxide delivery during cardiopulmonary bypass reduces postoperative morbidity in children--a randomized trial. Journal of Thoracic and Cardiovascular Surgery 2013;146(3):530-6. [MEDLINE: 23228403]
7. Khazin V, Kaufman Y, Zabeeda D, Medalion B, Sasson L, Schachner A, et al. Milrinone and nitric oxide: combined effect on pulmonary artery pressures after cardiopulmonary bypass in children. Journal of Cardiothoracic and Vascular Anesthesia 2004;18(2):156-9. [MEDLINE: PMID: 15073704]
8. Kirbas A, Yalcin Y, Tanrikulu N, Gürer O, Isik O. Comparison of inhaled nitric oxide and aerosolized iloprost in pulmonary hypertension in children with congenital heart surgery. Cardiology Journal 2012;19(4):387-94. [MEDLINE: 22825900]
9. Loukanov T, Bucsenez D, Springer W, Sebening C, Rauch H, Roesch E, et al. Comparison of inhaled nitric oxide with aerosolized iloprost for treatment of pulmonary hypertension in children after cardiopulmonary bypass surgery. Clinical Research in Cardiology 2011;100(7):595-602. [MEDLINE: PMID: 21318559]
10. Matsui J, Yahagi N, Kumon K, Hayashi H, Watanabe Y, Haruna M, et al. Effects of inhaled nitric oxide on postoperative pulmonary circulation in patients with congenital heart disease. Artificial Organs 1997;21(1):17-20. [MEDLINE: PMID: 9012900]
11. Smith HA, Carter JA, Christian KG, Drinkwater DC, Scholl FG, Christman BW, et al. Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral citrulline. Journal of Thoracic and Cardiovascular Surgery 2006;132(1):58-65. [MEDLINE: PMID: 16798303]
12. Alderson P, Green S, editors. Cochrane Collaboration open learning material for reviewers (Version 1.1, November 2002). www.cochrane-net.org/openlearning/HTML/modA2-3.htm.
13. Atz AM, Wessel DL. Inhaled nitric oxide in the neonate with cardiac disease. Seminars in Perinatology 1997;21(5):441-55. [MEDLINE: 9352616]
14. Bando K, Turrentine MW, Sharp TG, Sekine Y, Aufiero TX, Sun K, et al. Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management. Journal of Thoracic and Cardiovascular Surgery 1996;112(6):1600-9. [MEDLINE: 8975852]
15. Beghetti M, Habre W, Berner M. Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. British Heart Journal 1995;73(1):65-8. [MEDLINE: 7888265]
16. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. New England Journal of Medicine 2000;342(7):469-74. [MEDLINE: 10675427]
17. Cochrane Neonatal Review Group. Organization of a systematic review for the Cochrane Neonatal Review Group. Guidelines for reviewers and editors. www.cochrane.mcmaster.ca/neonatal/.
18. Curran RD, Mavroudis C, Backer CL, Sautel M, Zales VR, Wessel DL. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension. Annals of Thoracic Surgery 1995;60(6):1765-71. [MEDLINE: 8787478]
19. DiBlasi RM, Myers TR, Hess DR. Evidence-based clinical practice guideline: inhaled nitric oxide for neonates with acute hypoxic respiratory failure. Respiratory Care 2010;55(12):1717-45. [MEDLINE: 21122181]
20. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309:1286-9. [MEDLINE: 7718048]
21. Finer N, Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database of Systematic Reviews 2006, Issue 11. [DOI: 10.1002/14651858.CD000399]
22. Gorenflo M, Gu H, Xu Z. Peri-operative pulmonary hypertension in paediatric patients: current strategies in children with congenital heart disease. Cardiology 2010;116(1):10-7. [MEDLINE: 20424447]
23. Haworth SG. Pulmonary vascular disease in different types of congenital heart disease. Implications for interpretation of lung biopsy findings in early childhood. British Heart Journal 1984;52(5):557-71. [MEDLINE: 6498033]
24. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
25. Jones OD, Shore DF, Rigby ML, Leijala M, Scallan J, Shinebourne EA, et al. The use of tolazoline hydrochloride as a pulmonary vasodilator in potentially fatal episodes of pulmonary vasoconstriction after cardiac surgery in children. Circulation 1981;64(2 Part 2):II134-9. [MEDLINE: 7249314]
26. Journois D, Pouard P, Mauriat P, Malhere T, Vouhe P, Safran D. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart disease. Journal of Thoracic and Cardiovascular Surgery 1994;107(4):1129-35. [MEDLINE: 8159035]
27. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340(8823):819-20. [MEDLINE: 1357246]
28. Lefebvre C, McDonald S. Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE. Paper presented at the Fourth International Cochrane Colloquium. 20-24 October, 1996.
29. Miller OI, Celermajer DS, Deanfield JE, Macrae DJ. Very low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. Journal of Thoracic and Cardiovascular Surgery 1994;108(3):487-94. [MEDLINE: 8078341]
30. Nelin LD, Hoffman GM. The use of inhaled nitric oxide in a wide variety of clinical problems. Pediatric Clinics of North America 1998;45(3):531-48. [MEDLINE: 9653435]
31. Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. New England Journal of Medicine 1997;336(9):597-604. [MEDLINE: 9036320]
32. RevMan 5.2. Review Manager (RevMan) [Computer program]. Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
33. Roberts JD, Polaner DM, Lang P. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340(8823):818-9. [MEDLINE: 1357245]
34. Roberts JD, Fineman JR, Morin FC, Shawl PW, Rimar S, Schreiber MD, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. New England Journal of Medicine 1997;336(9):605-10. [MEDLINE: 9032045]
35. Steudel W, Hurford WE, Zapol WM. Inhaled nitric oxide. Basic biology and clinical applications. Anesthesiology 1999;91(4):1090-121. [MEDLINE: 10519513]
36. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993;88 Suppl 1:2128-38. [MEDLINE: 8222107]
37. Wheller J, George BL, Mulder DG, Jarmakani JM. Diagnosis and management of postoperative pulmonary hypertensive crisis. Circulation 1979;60(7):1640-4. [MEDLINE: 498483]
38. Whittsett JA, Pryhuber GS, Rice WR, Warner BB, Wert SE. Acute respiratory disorders. In: Avery GB, Fletcher MA, MacDonald MG editor(s). Neonatology. Pathophysiology and Management of the Newborn. 5th Edition. Philadelphia: Lippincott, Williams, & Wilkins, 1999:499-500.
39. Bizzarro M, Gross I. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD005055.pub2]